CAR-T Meeting 2023 | Exploring novel humanized anti-CD19 CAR-T cells as a strategy to minimize CRS and other toxicities
Gaurav Narula
• 9 Feb 2023
In this video, Gaurav Narula, MD, Tata Memorial Center, Mumbai, India, shares some insights into novel humanized anti-CD19 CAR-T cells being explored to minimize cytokine release syndrome (CRS), which have demonstrated promising results in pre-clinical and early-phase studies. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Scientific Advisory Board to ImmunoACT
